Nova Eye MedicalELXMF -0.03%55 Current Ratio is 1.85 as of Dec. 2025, which is 26% below its 10-year median of 2.50. GuruFocus rates ELXMF with a GF Score™ of 55/100 and a GF Value™ of $0.02. The stock has 4 warning signs investors should review. Among 855 Medical Devices & Instruments companies, Nova Eye Medical ranks worse than 65.03% on this metric.
The current ratio is a liquidity ratio that measures a company's ability to pay short-term obligations. It is calculated as a company's Total Current Assets divides by its Total Current Liabilities. Nova Eye Medical's current ratio for the quarter that ended in Dec. 2025 was 1.85.
Nova Eye Medical has a current ratio of 1.85. It generally indicates good short-term financial strength.
The historical rank and industry rank for Nova Eye Medical's Current Ratio or its related term are showing as below:
ELXMF'
s Current Ratio Range Over the Past 10 Years
Min: 1.47 Med: 2.5 Max: 7.17
Current: 1.85
During the past 13 years, Nova Eye Medical's highest Current Ratio was 7.17. The lowest was 1.47. And the median was 2.50.
ELXMF's Current Ratio is ranked worse than 65.03% of 855
companies
in the Medical Devices & Instruments industry
Industry Median: 2.48
vs ELXMF: 1.85
Nova Eye Medical (OTCPK:ELXMF) Current Ratio Explanation
The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.
Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.
The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.
If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.
Nova Eye Medical Current Ratio Related Terms
Nova Eye Medical Current Ratio Historical Data
* Premium members only.
The historical data trend for Nova Eye Medical's Current Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Nova Eye Medical's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Nova Eye Medical Current Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Nova Eye Medical's Current Ratio distribution charts can be found below:
* The bar in red indicates where Nova Eye Medical's Current Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Nova Eye Medical (ELXMF) has a Current Ratio of 1.85 as of Dec. 2025. This is 26% below median its historical median of 2.50. Over the past decade, Nova Eye Medical's Current Ratio has ranged from 1.47 to 7.17. According to the industry distribution chart, Nova Eye Medical ranks #556 out of 855 companies in the Medical Devices & Instruments industry, placing it in the top 65%.
Is Nova Eye Medical's Current Ratio too high?
Nova Eye Medical's current Current Ratio of 1.85 is 26% below median its 10-year median of 2.50. Over the past 10 years, this metric has ranged from a low of 1.47 to a high of 7.17. The Medical Devices & Instruments industry median Current Ratio is 2.48. Nova Eye Medical's value of 1.85 is 25.4% below this industry median. Based on the distribution chart, Nova Eye Medical ranks #556 out of 855 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Nova Eye Medical has a GF Score™ of 55/100, reflecting its overall financial health beyond just this single metric.
How does Nova Eye Medical's Current Ratio compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Nova Eye Medical ranks #556 out of 855 companies for Current Ratio. This places Nova Eye Medical in the lower half of its industry. The industry median Current Ratio is 2.48. Nova Eye Medical's value of 1.85 is 25.4% below this benchmark. Historically, Nova Eye Medical's own Current Ratio has ranged from 1.47 to 7.17 over the past decade. While the company's 10-year median is 2.50 vs. the industry median of 2.48, Nova Eye Medical has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Ratio for a Medical Devices & Instruments company?
The median Current Ratio among Medical Devices & Instruments companies is 2.48, based on 855 companies in the industry. Companies in the top quartile (top 25%) have a Current Ratio significantly above this median, while those in the bottom quartile fall well below. However, Current Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Nova Eye Medical's current Current Ratio of 1.85 is 25.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Ratio mean?
A high Current Ratio can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median Current Ratio is 2.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Nova Eye Medical's current Current Ratio is 1.85, which is 26% below median its own 10-year median of 2.50. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nova Eye Medical stock overvalued right now?
Nova Eye Medical (ELXMF) has a current Current Ratio of 1.85. The stock's GF Value™ is $0.02, compared to a current price of $0.01 — trading 28.5% below its estimated fair value. The current Current Ratio is 1.85, which is 26% below median its 10-year median of 2.50 and 25.4% below the Medical Devices & Instruments industry median of 2.48. Nova Eye Medical's overall GF Score™ is 55/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Ratio calculated?
Current Ratio is calculated from a company's financial statements. For Nova Eye Medical (ELXMF), the current Current Ratio is 1.85 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Nova Eye Medical (ELXMF) Overvalued in 2026?
Based on GuruFocus' analysis, Nova Eye Medical stock appears to be undervalued.
The current stock price of $0.01 is trading 28.5% below its estimated GF Value™ of $0.02.
Key valuation signals for ELXMF:
Current Ratio: 1.85 (26% below median its 10-year median of 2.50)
GF Value™: $0.02 vs. price of $0.01 (28.5% below fair value)
Industry Position: 25.4% below the Medical Devices & Instruments median (#556 of 855)
No single metric tells the full story. See the ELXMF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Nova Eye Medical Ltd develops and sells surgical devices for the treatment of glaucoma, a cause of blindness. In addition, the company is involved in the commercialisation of the subthreshold nano-pulse ophthalmic laser, 2RT, for the treatment of retinal disease via the AlphaRET segment. The company's reportable segments are: Glaucoma Surgical Devices and AlphaRET. The majority of its revenue is generated from the Glaucoma Surgical Devices segment, which is involved in the design, manufacture, marketing, and sale of the iTrack, iTrack Advance, and the Molteno3 glaucoma surgical device. These are all single-use surgical devices. Geographically, the company generates maximum revenue from the United States of America, followed by Europe, the Asia Pacific, Other regions, and Australia.
55GF Score
Get the complete analysis for ELXMF
Current Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ELXMF has been successfully added to your 
